
|Podcasts|May 10, 2021
Managing a changing landscape of IRD pediatric cases
Author(s)Alex Delaney-Gesing , Sheryl Stevenson
Advertisement
Ophthalmology Times®' Sheryl Stevenson speaks with Marc Mathias, MD, a retinal specialist from Children’s Hospital Colorado, who offers insight on managing cases of inherited retinal dystrophies in pediatric patients, as well as an update on the rapidly changing treatment landscape, thanks to ongoing clinical trials in novel IRD and genetic therapies.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
What ‘I’m Fine’ Really Means: An Open Letter from a Thyroid Eye Disease (TED) Patient
2
PolyActiva and RareSight partner to develop treatments for rare pediatric retinal diseases
3
Q&A: Advancing a long-acting anti-VEGF candidate: What it means for retinal disease
4
Opus Genetics has Type B RMAT meeting with FDA for its gene therapy candidate, OPGx-LCA5
5


















































.png)


